Home/Filings/4/0001144204-18-003702
4//SEC Filing

Gu Nana 4

Accession 0001144204-18-003702

CIK 0000850261other

Filed

Jan 24, 7:00 PM ET

Accepted

Jan 25, 4:57 PM ET

Size

9.2 KB

Accession

0001144204-18-003702

Insider Transaction Report

Form 4
Period: 2018-01-23
Transactions
  • Sale

    Common Stock

    2018-01-24$7.52/sh577,962$4,343,7318,617,513 total
  • Sale

    Common Stock

    2018-01-23$7.82/sh106,326$831,9589,195,475 total
Gu Nana
10% Owner
Transactions
  • Sale

    Common Stock

    2018-01-23$7.82/sh106,326$831,9589,195,475 total
  • Sale

    Common Stock

    2018-01-24$7.52/sh577,962$4,343,7318,617,513 total
Footnotes (3)
  • [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.75 to $8.00, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4.
  • [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.50 to $7.675, inclusive.
  • [F3]This Form 4 is being filed by Asia Pacific MedTech (BVI) Limited as the direct beneficial owner of the shares of Common Stock. Nana Gu is the indirect beneficial owner of the shares of Common Stock in her capacity as the sole director and sole shareholder of Asia Pacific MedTech (BVI) Limited.

Issuer

Sorrento Therapeutics, Inc.

CIK 0000850261

Entity typeother

Related Parties

1
  • filerCIK 0001705658

Filing Metadata

Form type
4
Filed
Jan 24, 7:00 PM ET
Accepted
Jan 25, 4:57 PM ET
Size
9.2 KB